Table 1.
The Association of miR-942-3p Expression With Clinicopathologic Characteristics in Patients With HCC.
| Variables | Cases (n) | miR-942-3p | P Value | |
|---|---|---|---|---|
| High | Low | |||
| Total | 260 | 14 | 246 | |
| Age (years) | ||||
| ≥60 | 136 | 6 | 130 | |
| <60 | 124 | 8 | 116 | .325 |
| Gender | ||||
| Male | 173 | 10 | 163 | |
| Female | 87 | 4 | 83 | .469 |
| Pathological stage | ||||
| Ⅰ/Ⅱ | 191 | 7 | 184 | |
| Ⅲ/Ⅳ | 69 | 7 | 62 | .047 |
| TNM stage | ||||
| T1/T2 | 194 | 7 | 187 | |
| T3/T4 | 66 | 7 | 59 | .037 |
| Lymphatic invasion | ||||
| Negative | 191 | 11 | 180 | |
| Positive | 69 | 3 | 66 | .465 |
| Distant metastasis | ||||
| Negative | 206 | 11 | 195 | |
| Positive | 54 | 3 | 51 | .585 |
TNM: tumor node metastasis.